Abbott Laboratories (ABT) FCF Margin (2009 - 2026)
Abbott Laboratories (ABT) posted FCF Margin of 15.81% for Q2 2026, up 92.69% sequentially from 8.2% in Q1 2026, and up 194.0% YoY from 5.38% in Q2 2025.
Abbott Laboratories (ABT) FCF Margin (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported FCF Margin for 18 years, with the latest figure at 15.81% in Q2 2026.
- Quarterly FCF Margin rose 194.0% year-over-year to 15.81% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 16.8% (up 108.0% YoY) and the FY2025 annual result came in at 16.68%, up 154.0% from the prior year.
- FCF Margin advanced to 15.81% in Q2 2026 per ABT's latest filing, from 8.2% in the prior quarter.
- Over five years, FCF Margin peaked at 22.92% in Q4 2025 and troughed at 6.29% in Q1 2024.
- A 5-year average of 15.1% and a median of 15.24% in 2022 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2023 and 2024: FCF Margin tumbled 1107 bps in 2023, then jumped 722 bps in 2024.
- Over 5 years, FCF Margin stood at 17.01% in 2022, then soared by 31 bps to 22.29% in 2023, then dropped by 12 bps to 19.57% in 2024, then grew by 17 bps to 22.92% in 2025, then slumped by 31 bps to 15.81% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 15.81%, 8.2%, and 22.92% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 15.81% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 16.07% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 23.50% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 33.60% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 14.10% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 1.28% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 5.32% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 18.73% |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 18.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.81% |
| Mar 31, 2026 | 8.20% |
| Dec 31, 2025 | 22.92% |
| Sep 30, 2025 | 20.15% |
| Jun 30, 2025 | 13.87% |
| Mar 31, 2025 | 9.01% |
| Dec 31, 2024 | 19.57% |
| Sep 30, 2024 | 20.21% |
| Jun 30, 2024 | 13.75% |
| Mar 31, 2024 | 6.29% |
| Dec 31, 2023 | 22.29% |
| Sep 30, 2023 | 12.98% |
| Jun 30, 2023 | 6.98% |
| Mar 31, 2023 | 7.83% |
| Dec 31, 2022 | 17.01% |
| Sep 30, 2022 | 22.22% |
| Jun 30, 2022 | 18.04% |
| Mar 31, 2022 | 14.66% |
| Dec 31, 2021 | 21.39% |
| Sep 30, 2021 | 20.50% |